“Treatment outcome in patients with HCV Genotype-3a Infection, Treated with 24-Weeks Dual Therapy (Sofosbuvir and Ribavirin)” (2024) Medical Forum Monthly, 28(11). Available at: https://medicalforummonthly.com/index.php/mfm/article/view/4275 (Accessed: 1 February 2026).